These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36444865)

  • 1. Automated Quantification of Abnormal QRS Peaks From High-Resolution ECGs Predicts Late Ventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 5-Year Prospective Multicenter Study.
    Suszko AM; Chakraborty P; Viswanathan K; Barichello S; Sapp J; Talajic M; Laksman Z; Yee R; Woo A; Spears D; Adler A; Rakowski H; Chauhan VS
    J Am Heart Assoc; 2022 Dec; 11(23):e026025. PubMed ID: 36444865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Quantification of Low-Amplitude Abnormal QRS Peaks From High-Resolution ECG Recordings Predicts Arrhythmic Events in Patients With Cardiomyopathy.
    Das M; Suszko AM; Nayyar S; Viswanathan K; Spears DA; Tomlinson G; Pinter A; Crystal E; Dalvi R; Krishnan S; Chauhan VS
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28705874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvolt QRS Alternans in Hypertrophic Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.
    Chakraborty P; Suszko AM; Viswanathan K; Sheikholeslami K; Spears D; Adler A; Woo A; Rakowski H; Chauhan VS
    J Am Heart Assoc; 2021 Dec; 10(23):e022036. PubMed ID: 34854315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of abnormal QRS peaks predicts response to cardiac resynchronization therapy and tracks structural remodeling.
    Suszko AM; Nayyar S; Porta-Sanchez A; Das M; Pinter A; Crystal E; Tomlinson G; Dalvi R; Chauhan VS
    PLoS One; 2019; 14(6):e0217875. PubMed ID: 31170231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
    Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
    Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
    Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study.
    Schulze Lammers S; Lawrenz T; Lawin D; Hoyer A; Stellbrink C; Albrecht UV
    JMIR Res Protoc; 2023 Dec; 12():e52035. PubMed ID: 38157231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS fragmentation is associated with increased risk of ventricular arrhythmias in high-risk patients; Data from the SMASH 1 Study.
    Sourour N; Riveland E; Rømo T; Naesgaard P; Kjekshus H; Larsen AI; Omland T; Røsjø H; Myhre PL
    Ann Noninvasive Electrocardiol; 2022 Sep; 27(5):e12985. PubMed ID: 35839068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
    Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
    Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ
    Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy (from the CILICIA Registry).
    Güner A; Kalçık M; Çelik M; Uzun F; Çizgici AY; Ağuş HZ; Aslan S; Güner EG; Ulutaş AE; Bayam E; Kalkan ME
    J Electrocardiol; 2020; 63():83-90. PubMed ID: 33142186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
    Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.
    Balaji S; DiLorenzo MP; Fish FA; Etheridge SP; Aziz PF; Russell MW; Tisma S; Pflaumer A; Sreeram N; Kubus P; Law IH; Kantoch MJ; Kertesz NJ; Strieper M; Erickson CC; Moore JP; Nakano SJ; Singh HR; Chang P; Cohen M; Fournier A; Ilina MV; Smith RT; Zimmerman F; Horndasch M; Li W; Batra A; Liberman L; Hamilton R; Janson CM; Sanatani S; Zeltser I; McDaniel G; Blaufox AD; Garnreiter JM; Katcoff H; Shah M
    Heart Rhythm; 2019 Oct; 16(10):1462-1467. PubMed ID: 31026510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECG-derived spatial QRS-T angle is strongly associated with hypertrophic cardiomyopathy.
    Cortez D; Schlegel TT; Ackerman MJ; Bos JM
    J Electrocardiol; 2017; 50(2):195-202. PubMed ID: 27839835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.
    Suszko A; Nayyar S; Labos C; Nanthakumar K; Pinter A; Crystal E; Chauhan VS
    J Am Heart Assoc; 2020 Sep; 9(17):e016461. PubMed ID: 32806990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.
    Shiozaki AA; Senra T; Arteaga E; Martinelli Filho M; Pita CG; Ávila LF; Parga Filho JR; Mady C; Kalil-Filho R; Bluemke DA; Rochitte CE
    J Cardiovasc Comput Tomogr; 2013; 7(3):173-81. PubMed ID: 23849490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.